Shoji Matsune
Overview
Explore the profile of Shoji Matsune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamashita Y, Hosoya K, Fujiwara Y, Saito Y, Yoshida M, Matsune S, et al.
Gels
. 2025 Jan;
11(1).
PMID: 39852031
After endoscopic sinus surgery (ESS), nasal packing is often used to stop bleeding and promote wound healing. Because maintaining a moist environment is important to enhance wound healing, hydrogel-based wound...
2.
Oka A, Kanai K, Matsune S, Hosoya K, Komachi T, Murakami R, et al.
Allergy
. 2024 Oct;
80(2):614-616.
PMID: 39412479
No abstract available.
3.
Makihara S, Hosoya K, Uraguchi K, Maeda Y, Komachi T, Yorifuji T, et al.
Auris Nasus Larynx
. 2024 Jul;
51(5):834-839.
PMID: 39068831
Objective: There is no consensus on the optimal surgical technique for allergic rhinitis (AR). Furthermore, the appropriateness of surgical intervention in children and older individuals remains debatable. This study aimed...
4.
Yoshioka Y, Matsune S, Sekine K, Ishida M, Wakayama N, Yamaguchi S, et al.
Auris Nasus Larynx
. 2023 Oct;
51(2):236-241.
PMID: 37813729
Objective: In children with obstructive sleep apnea (OSA) who underwent adenotonsillectomy (AT), we measured body height and weight using standard deviation (SD) scores, insulin-like growth factor 1 (IGF-1), and skeletal...
5.
Fujieda S, Matsune S, Takeno S, Ohta N, Asako M, Bachert C, et al.
Allergy
. 2021 May;
77(1):186-196.
PMID: 33993501
Background: The human monoclonal antibody dupilumab blocks interleukin (IL)-4 andIL-13, key and central drivers of type 2 inflammation. Dupilumab, on background mometasone furoate nasal spray (MFNS), improved outcomes in the...
6.
Fujieda S, Matsune S, Takeno S, Asako M, Takeuchi M, Fujita H, et al.
Laryngoscope
. 2020 Nov;
131(6):E1770-E1777.
PMID: 33226139
Objectives/hypothesis: Dupilumab, which blocks the shared receptor component for interleukin-4 and interleukin-13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with...
7.
Otsuka K, Otsuka H, Matsune S, Okubo K
Immun Inflamm Dis
. 2020 May;
8(3):333-341.
PMID: 32468704
Background And Objective: Nasal symptoms were reduced following allergen-specific sublingual immunotherapy (SLIT) for allergic rhinitis. The mechanisms underlying the effectiveness of SLIT for Japanese cedar pollinosis are poorly understood. We...
8.
Otsuka K, Otsuka H, Matsune S, Okubo K
Immun Inflamm Dis
. 2020 Apr;
8(3):258-266.
PMID: 32239697
Background And Objective: Nasal symptoms of allergic rhinitis can be reduced with allergen-specific subcutaneous immunotherapy (SCIT). However, the mechanisms underlying the effectiveness of SCIT for Japanese cedar pollinosis are not...
9.
Takahara E, Matsune S, Ishida M, Wakayama N, Okubo K
J Nippon Med Sch
. 2020 Feb;
87(5):277-284.
PMID: 32074537
Background: As part of the planning for a future multicenter study, this preliminary clinical trial used serum samples from patients to identify biomarkers for predicting the therapeutic effects of sublingual...
10.